Literature DB >> 23864442

Do very preterm twins and singletons differ in their neurodevelopment at 5 years of age?

Florence Bodeau-Livinec1, Jennifer Zeitlin, Béatrice Blondel, Catherine Arnaud, Jeanne Fresson, Antoine Burguet, Damien Subtil, Stéphane Marret, Jean-Christophe Rozé, Laetitia Marchand-Martin, Pierre-Yves Ancel, Monique Kaminski.   

Abstract

OBJECTIVE: Twins have inconsistently shown poorer outcomes than singletons. Although a high proportion of twins are born very preterm, data are sparse on the long-term outcomes in very preterm twins. The objective of this study was to compare mortality and neurodevelopmental outcomes of very preterm singletons and twins and to study outcomes in relation to factors specific to twins.
DESIGN: Birth cohort study Etude Epidemiologique sur les Petits Ages Gestationnels (EPIPAGE).
SETTING: Nine regions in France. PATIENTS: All very preterm live births occurring from 22 to 32 weeks of gestation in all maternity wards of nine French regions in 1997 (n=2773). MAIN OUTCOMES MEASURES: Neurodevelopmental status, including cerebral palsy, and a cognitive assessment with the Kaufman Assessment Battery for Children, with scores on the Mental Processing Composite (MPC) scale, was available for 1732 and 1473 children at 5 years of age, respectively.
RESULTS: Among live births, twins had higher hospital mortality than singletons (adjusted (a)OR: 1.4 (95% CI 1.1 to 1.9)). Among survivors, there was no crude difference at 5 years between twins and singletons in the prevalence of cerebral palsy (8.0% vs 9.1%, respectively), MPC <70 (9.5% vs 11.1%) and mean MPC (94.6 vs 94.4). However, after adjustment for sex, gestational age, intrauterine growth restriction and social factors, twins were more likely to have lower MPC scores (mean difference: -2.4 (95% CI-4.8 to 0.01)). Live born twins had a higher risk of mortality when birth weight discordance was present (aOR:2.9 (95% CI 1.7 to 4.8)), but there were no differences in long-term outcomes.
CONCLUSIONS: Compared with very preterm singletons, twins had higher mortality, no difference with respect to severe deficiencies, but slightly lower MPC scores at 5 years.

Entities:  

Keywords:  Epidemiology; Fetal Medicine; Neurodevelopment; Neurodisability; Twins

Mesh:

Year:  2013        PMID: 23864442     DOI: 10.1136/archdischild-2013-303737

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN: 1359-2998            Impact factor:   5.747


  6 in total

1.  Trends in the prevalence of cerebral palsy among very preterm infants (<31 weeks' gestational age).

Authors:  Michael J Vincer; Alexander C Allen; Victoria M Allen; Thomas F Baskett; Colleen M O'Connell
Journal:  Paediatr Child Health       Date:  2014-04       Impact factor: 2.253

2.  Impact of ART on pregnancies in California: an analysis of maternity outcomes and insights into the added burden of neonatal intensive care.

Authors:  T A Merritt; M Goldstein; R Philips; R Peverini; J Iwakoshi; A Rodriguez; B Oshiro
Journal:  J Perinatol       Date:  2014-02-20       Impact factor: 2.521

3.  Neurodevelopmental Outcomes of Twins Compared With Singleton Children: A Systematic Review.

Authors:  Oluwole A Babatunde; Sally N Adebamowo; IkeOluwa O Ajayi; Clement A Adebamowo
Journal:  Twin Res Hum Genet       Date:  2018-02-08       Impact factor: 1.587

4.  Multiple birth rates of Korea and fetal/neonatal/infant mortality in multiple gestation.

Authors:  Hyun Sun Ko; Jeong Ha Wie; Sae Kyung Choi; In Yang Park; Yong-Gyu Park; Jong Chul Shin
Journal:  PLoS One       Date:  2018-08-15       Impact factor: 3.240

5.  Functional development of preterm children born from singleton and multiple pregnancies: Preliminary study.

Authors:  Aneta M Suder; Agnieszka J Gniadek; Agnieszka M Micek; Dorota W Pawlik
Journal:  J Mother Child       Date:  2021-10-11

6.  Variations in Multiple Birth Rates and Impact on Perinatal Outcomes in Europe.

Authors:  Anna Heino; Mika Gissler; Ashna D Hindori-Mohangoo; Béatrice Blondel; Kari Klungsøyr; Ivan Verdenik; Ewa Mierzejewska; Petr Velebil; Helga Sól Ólafsdóttir; Alison Macfarlane; Jennifer Zeitlin
Journal:  PLoS One       Date:  2016-03-01       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.